glp-1 news 2025 november 25 Pipeline Update: - Prime Therapeutics FDA issued 25 warning letters
Description
Discover evidence-based strategies to break a weight loss stall on tirzepatide
GLP-1 agonists offer metabolic and anti-inflammatory benefits, but appetite suppression may drive gut microbiome dysbiosis that offsets long-term outcomes.
*Benefits as shown are reported in ingredient-specific studies
In this episode of unPAUSED, Dr
Dive into the history and overview of GLP-1s in our 2-minute video.
Many users experience fast relief from nausea and digestive discomfort within the first week of using PeptideComfort
